Drug Shortage Report for BROMAZEPAM-3 - TAB 3MG

Last updated on 2019-04-11 History
Report ID 71896
Drug Identification Number 02220520
Brand name BROMAZEPAM-3 - TAB 3MG
Common or Proper name BROMAZEPAM - 3
Company Name PRO DOC LIMITEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) BROMAZEPAM
Strength(s) 3MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-01-10
Estimated end date
Actual end date 2019-04-10
Shortage status Resolved
Updated date 2019-04-11
Company comments Discontinued Discontinué
Health Canada comments
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2019-04-11 English Compare
v19 2019-04-10 French Compare
v18 2019-04-10 English Compare
v17 2019-04-10 French Compare
v16 2019-04-10 English Compare
v15 2019-03-22 French Compare
v14 2019-03-22 English Compare
v13 2019-03-21 French Compare
v12 2019-03-21 English Compare
v11 2019-03-13 French Compare
v10 2019-03-13 English Compare
v9 2019-03-05 French Compare
v8 2019-03-05 English Compare
v7 2019-02-12 French Compare
v6 2019-02-12 English Compare
v5 2019-01-21 French Compare
v4 2019-01-21 English Compare
v3 2019-01-11 English Compare
v2 2019-01-10 French Compare
v1 2019-01-10 English Compare